| T1 Clinical efficacy | T1 Total efficacy | T2 Clinical efficacy | T2 Total efficacy |
---|
| Markedly effective | Effective | Ineffective | Total Effective | Ineffective | Markedly effective | Effective | Ineffective | Total Effective | Ineffective |
---|
STOFMS | 143(0.74) | 33(0.17) | 17(0.09) | 176(0.91) | 17(0.09) | 144(0.75) | 26(0.14) | 23(0.12) | 170(0.88) | 23(0.12) |
Control | 108(0.57) | 60(0.31) | 23(0.12) | 168(0.88) | 23(0.12) | 116(0.61) | 37(0.19) | 38(0.20) | 153(0.80) | 38(0.20) |
x2
| 13.609 | 1.076 | 8.614 | 4.573 |
P | 0.001 | 0.300 | 0.013 | 0.032 |
- Note: Markedly effective: EEG returned to normal after treatment, clinical symptoms were completely relieved, and the frequency of seizures was reduced by more than 70%
- Effective: EEG was generally normal, clinical symptoms were significantly improved, and the frequency of seizures was reduced by 50%
- Ineffective: EEG and clinical symptoms were not significantly improved after treatment, and the frequency of seizures was reduced by 50% or less or there was no change
- The total effective cases were markedly effective cases + effective cases